Mega Contracts Monitor ($100M+) — July 30, 2026

UnitedHealth Group subsidiary secured a $572.2M firm-fixed-price delivery order under full and open competition, indicating competitive strength and a potentially high-margin, short-duration revenue event. The absence of set-asides and the low pricing risk (fixed-price) are positive signals for UnitedHealth Group's federal healthcare margins.

Across nine VA awards to Optum, total obligations are $6.49B but outlayed funds are $0, and all performance periods are only one month (January-March 2026). This creates material revenue recognition risk and suggests these may be placeholder obligations or funding increments rather than executable programs.

Booz Allen Hamilton's 5-year, $598.7M cost-plus-award-fee delivery order at Aberdeen Proving Ground runs through September 2023. The negative outlayed amount (-$218,053) and near-term expiration create both re-compete catalyst potential and execution risk for Booz Allen's federal engineering services revenue.

Nine Optum VA contracts totaling $6.49B have zero outlayed funds and single-month performance periods (Jan-Mar 2026). If these are not executed, UnitedHealth Group's federal segment revenue could miss expectations by a material amount.

90% of total contract value ($6.49B of $7.09B) is awarded to a single contractor (Optum/UnitedHealth Group) from a single agency (VA). This extreme concentration exposes UnitedHealth Group to VA budget risk, policy changes, and protest risk from competitors.

All nine Optum VA contracts are structured as single-month delivery orders with no options, suggesting tactical procurement rather than long-term program funding. This makes them vulnerable to Continuing Resolution (CR) disruptions if Congress fails to pass a full-year VA appropriations bill.

Booz Allen Hamilton's $598.7M GSA engineering contract expires September 2023 with a negative outlayed amount, suggesting potential performance issues or funding clawbacks. The re-compete could be contested by competitors like CACI, Leidos, or SAIC.

The VA's $6.49B in single-month managed healthcare awards to Optum signals sustained or growing demand for private-sector health insurance administration. If these are monthly funding increments under a larger IDIQ, UnitedHealth Group could see recurring revenue at similar monthly run rates.

Booz Allen Hamilton's $598.7M GSA engineering contract at Aberdeen Proving Ground, while expiring, demonstrates continued federal investment in engineering services. A successful re-compete win could provide a 5-year revenue stream of ~$120M annually.

The Department of Veterans Affairs awarded $6.49B in single-month contracts to Optum Public Sector Solutions, indicating a strategic shift toward private-sector health insurance administration for veteran care. This represents a massive, concentrated outsourcing of managed healthcare services.

100% of the $7.09B in mega-contracts this period are civilian (VA and GSA), with 91.5% awarded to a single contractor (Optum/UNH). This extreme concentration creates binary risk for investors: either UNH captures massive revenue or faces material shortfalls if contracts are not executed.

{"entity" => "UnitedHealth Group (UNH)", "reason" => "Nine VA contracts totaling $6.49B with zero outlayed funds and single-month durations create binary revenue risk for the federal segment.", "trigger" => "Q1 2026 earnings report (expected late April 2026) for revenue recognition from January-March 2026 performance periods"}

{"entity" => "Booz Allen Hamilton (BAH)", "reason" => "The $598.7M GSA engineering contract expires September 2023; re-compete outcome will impact ~$120M annual revenue stream.", "trigger" => "GSA FEDSIM re-compete solicitation release or award announcement"}

{"entity" => "Department of Veterans Affairs", "reason" => "VA is the dominant awarding agency (90% of total value); any budget cuts or policy changes would directly impact Optum/UNH revenue.", "trigger" => "FY2027 VA budget request release (expected February 2027) and Congressional appropriations process"}